L
Leif Bertilsson
Researcher at Karolinska University Hospital
Publications - 321
Citations - 24620
Leif Bertilsson is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Debrisoquine & Debrisoquin. The author has an hindex of 87, co-authored 321 publications receiving 23933 citations. Previous affiliations of Leif Bertilsson include Astra & University of Oulu.
Papers
More filters
Journal ArticleDOI
Aging-induced Changes in Acetylcholine and Serotonin Content of Discrete Brain Nuclei
Journal ArticleDOI
S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin.
TL;DR: Coadministration of debrisoquin and mephenytoin before bedtime and urine collection during two consecutive nights allow for an accurate determination of both phenotypes in the population.
Journal ArticleDOI
Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.
Juan Antonio Carrillo,Magnus Christensen,Sara I. Ramos,Christina Alm,Marja-Liisa Dahl,Julio Benítez,Leif Bertilsson +6 more
TL;DR: Among caffeine-based approaches for CYP1A2, the authors recommend either plasma or saliva 17X/ 137X ratio and the urinary (AFMU + 1U + 1X + 17U + 17X)/137X ratio during a sampling interval of at least 8 hours, starting at time zero since caffeine intake.
Journal ArticleDOI
CYP2C19 genotype and phenotype determined by omeprazole in a Korean population.
TL;DR: A high incidence of PMs of omeprazole in Koreans is confirmed and of the 32 Korean PMs 97% could be identified by the genotype analysis, and only one PM subject was found to be heterozygous for the *1 and *2 alleles.
Journal ArticleDOI
Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamics of tolterodine
TL;DR: To determine whether cytochrome P450 2D6 (CYP2D6) is involved in the metabolism of tolterodine by investigating potential differences in pharmacokinetics and pharmacodynamics between poor metabolizers and extensive metabolizers of debrisoquin (INN, debrisoquine).